Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Clarke, Christina A.
Canchola, Alison J.
Moy, Lisa M.
Neuhausen, Susan L.
Chung, Nadia T.
Lacey, James V.
Funding for this research was provided by:
National Cancer Institute (R01 CA77398)